View Financial HealthMedical Packaging 配当と自社株買い配当金 基準チェック /06Medical Packaging配当金を支払った記録がありません。主要情報n/a配当利回りn/aバイバック利回り総株主利回りn/a将来の配当利回りn/a配当成長n/a次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向n/a最近の配当と自社株買いの更新更新なしすべての更新を表示Recent updatesNew Risk • May 22New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 25% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (25% accrual ratio). Minor Risks Revenue is less than US$5m (ج.م133m revenue, or US$2.7m). Market cap is less than US$100m (ج.م831.9m market cap, or US$16.7m).お知らせ • Mar 20Medical Packaging Company, Annual General Meeting, Apr 12, 2025Medical Packaging Company, Annual General Meeting, Apr 12, 2025, at 13:00 Egypt Standard Time. Location: cairo EgyptReported Earnings • Aug 18Second quarter 2024 earnings released: EPS: ج.م0.021 (vs ج.م0.007 in 2Q 2023)Second quarter 2024 results: EPS: ج.م0.021 (up from ج.م0.007 in 2Q 2023). Revenue: ج.م29.0m (up 72% from 2Q 2023). Net income: ج.م13.8m (up 224% from 2Q 2023). Profit margin: 48% (up from 25% in 2Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 143% per year but the company’s share price has only increased by 35% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Jul 24Investor sentiment improves as stock rises 25%After last week's 25% share price gain to ج.م1.30, the stock trades at a trailing P/E ratio of 64.9x. Average trailing P/E is 6x in the Packaging industry in Africa. Total returns to shareholders of 169% over the past three years.New Risk • Mar 31New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Egyptian stocks, typically moving 13% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (13% average weekly change). Minor Risks Profit margins are more than 30% lower than last year (2.3% net profit margin). Revenue is less than US$5m (ج.م91m revenue, or US$1.9m). Market cap is less than US$100m (ج.م1.47b market cap, or US$31.1m).Reported Earnings • Mar 07Full year 2023 earnings released: EPS: ج.م0.032 (vs ج.م0.017 in FY 2022)Full year 2023 results: EPS: ج.م0.032. Revenue: ج.م91.0m (up 54% from FY 2022). Net income: ج.م2.10m (down 63% from FY 2022). Profit margin: 2.3% (down from 9.7% in FY 2022). The decrease in margin was driven by higher expenses.Reported Earnings • Nov 18Third quarter 2022 earnings released: EPS: ج.م7.00 (vs ج.م0.004 in 3Q 2021)Third quarter 2022 results: EPS: ج.م7.00 (up from ج.م0.004 in 3Q 2021). Revenue: ج.م15.5m (up 25% from 3Q 2021). Net income: ج.م2.37m (up 54% from 3Q 2021). Profit margin: 15% (up from 12% in 3Q 2021). The increase in margin was driven by higher revenue.New Risk • Nov 07New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Egyptian stocks, typically moving 8.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported June 2022 fiscal period end). Shareholders have been substantially diluted in the past year (90% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (8.6% average weekly change). Revenue is less than US$5m (ج.م53m revenue, or US$1.7m). Market cap is less than US$100m (ج.م662.9m market cap, or US$21.5m).Valuation Update With 7 Day Price Move • Nov 07Investor sentiment improves as stock rises 41%After last week's 41% share price gain to ج.م1.01, the stock trades at a trailing P/E ratio of 75.3x. Average trailing P/E is 8x in the Packaging industry in Africa. Total returns to shareholders of 207% over the past three years.Buying Opportunity • Oct 08Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 24%. The fair value is estimated to be ج.م0.80, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 32% over the last year. Earnings per share has grown by 47%.New Risk • Aug 17New major risk - Financial data availabilityThe company's latest financial reports are more than a year old. Last reported fiscal period ended June 2022. This is considered a major risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. In the worst case scenario, it may be facing other major going concern issues jeopardizing its viability as a listed company. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported June 2022 fiscal period end). Share price has been highly volatile over the past 3 months (16% average weekly change). Shareholders have been substantially diluted in the past year (90% increase in shares outstanding). Minor Risks Revenue is less than US$5m (ج.م53m revenue, or US$1.7m). Market cap is less than US$100m (ج.م472.3m market cap, or US$15.3m).Buying Opportunity • Feb 24Now 25% undervalued after recent price dropOver the last 90 days, the stock is down 23%. The fair value is estimated to be ج.م0.37, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 22% per annum over the last 3 years. The company has become profitable over the last 3 years.Is New 90 Day High Low • Mar 16New 90-day high: ج.م1.06The company is up 121% from a price of ج.م0.48 on 16 December 2020. Outperformed the Egyptian market which is up 4.0% over the last 90 days. Exceeded the Packaging industry, which is up 31% over the same period.Reported Earnings • Mar 07Full year 2020 earnings released: EPS ج.م0.01 (vs ج.م0.017 in FY 2019)The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2020 results: Revenue: ج.م36.7m (up 23% from FY 2019). Net income: ج.م4.41m (down 21% from FY 2019). Profit margin: 12% (down from 19% in FY 2019). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 103% per year but the company’s share price has only increased by 70% per year, which means it is significantly lagging earnings growth.Is New 90 Day High Low • Feb 01New 90-day high: ج.م0.81The company is up 134% from its price of ج.م0.35 on 03 November 2020. The Egyptian market is up 14% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Packaging industry, which is up 36% over the same period.Is New 90 Day High Low • Jan 13New 90-day high: ج.م0.64The company is up 58% from its price of ج.م0.41 on 15 October 2020. The Egyptian market is up 5.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Packaging industry, which is up 25% over the same period.Is New 90 Day High Low • Dec 17New 90-day high: ج.م0.53The company is up 14% from its price of ج.م0.46 on 17 September 2020. The Egyptian market is up 4.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Packaging industry, which is up 26% over the same period.Is New 90 Day High Low • Nov 02New 90-day low: ج.م0.34The company is down 9.0% from its price of ج.م0.38 on 04 August 2020. The Egyptian market is up 4.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Packaging industry, which is up 4.0% over the same period.お知らせ • Sep 17An unknown buyer acquired 11.4% stake in Medical Packaging Company (CASE:MEPA) from Wael Bebawy for EGP 15.6 million.An unknown buyer acquired 11.4% stake in Medical Packaging Company (CASE:MEPA) from Wael Bebawy for EGP 15.6 million on September 16, 2020. Wael Bebawy now holds 5.07% stake in Medical Packaging Company. An unknown buyer completed the acquisition of 11.4% stake in Medical Packaging Company (CASE:MEPA) from Wael Bebawy on September 16, 2020.決済の安定と成長配当データの取得安定した配当: MEPAの 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。増加する配当: MEPAの配当金が増加しているかどうかを判断するにはデータが不十分です。配当利回り対市場Medical Packaging 配当利回り対市場MEPA 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (MEPA)n/a市場下位25% (EG)1.4%市場トップ25% (EG)6.3%業界平均 (Packaging)6.0%アナリスト予想 (MEPA) (最長3年)n/a注目すべき配当: MEPAは最近配当金を報告していないため、配当金支払者の下位 25% に対して同社の配当利回りを評価することはできません。高配当: MEPAは最近配当金を報告していないため、配当金支払者の上位 25% に対して同社の配当利回りを評価することはできません。株主への利益配当収益カバレッジ: MEPAの 配当性向 を計算して配当金の支払いが利益で賄われているかどうかを判断するにはデータが不十分です。株主配当金キャッシュフローカバレッジ: MEPAが配当金を報告していないため、配当金の持続可能性を計算できません。高配当企業の発掘7D1Y7D1Y7D1YEG 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/21 23:57終値2026/05/21 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Medical Packaging Company 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
New Risk • May 22New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 25% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (25% accrual ratio). Minor Risks Revenue is less than US$5m (ج.م133m revenue, or US$2.7m). Market cap is less than US$100m (ج.م831.9m market cap, or US$16.7m).
お知らせ • Mar 20Medical Packaging Company, Annual General Meeting, Apr 12, 2025Medical Packaging Company, Annual General Meeting, Apr 12, 2025, at 13:00 Egypt Standard Time. Location: cairo Egypt
Reported Earnings • Aug 18Second quarter 2024 earnings released: EPS: ج.م0.021 (vs ج.م0.007 in 2Q 2023)Second quarter 2024 results: EPS: ج.م0.021 (up from ج.م0.007 in 2Q 2023). Revenue: ج.م29.0m (up 72% from 2Q 2023). Net income: ج.م13.8m (up 224% from 2Q 2023). Profit margin: 48% (up from 25% in 2Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 143% per year but the company’s share price has only increased by 35% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Jul 24Investor sentiment improves as stock rises 25%After last week's 25% share price gain to ج.م1.30, the stock trades at a trailing P/E ratio of 64.9x. Average trailing P/E is 6x in the Packaging industry in Africa. Total returns to shareholders of 169% over the past three years.
New Risk • Mar 31New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Egyptian stocks, typically moving 13% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (13% average weekly change). Minor Risks Profit margins are more than 30% lower than last year (2.3% net profit margin). Revenue is less than US$5m (ج.م91m revenue, or US$1.9m). Market cap is less than US$100m (ج.م1.47b market cap, or US$31.1m).
Reported Earnings • Mar 07Full year 2023 earnings released: EPS: ج.م0.032 (vs ج.م0.017 in FY 2022)Full year 2023 results: EPS: ج.م0.032. Revenue: ج.م91.0m (up 54% from FY 2022). Net income: ج.م2.10m (down 63% from FY 2022). Profit margin: 2.3% (down from 9.7% in FY 2022). The decrease in margin was driven by higher expenses.
Reported Earnings • Nov 18Third quarter 2022 earnings released: EPS: ج.م7.00 (vs ج.م0.004 in 3Q 2021)Third quarter 2022 results: EPS: ج.م7.00 (up from ج.م0.004 in 3Q 2021). Revenue: ج.م15.5m (up 25% from 3Q 2021). Net income: ج.م2.37m (up 54% from 3Q 2021). Profit margin: 15% (up from 12% in 3Q 2021). The increase in margin was driven by higher revenue.
New Risk • Nov 07New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Egyptian stocks, typically moving 8.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported June 2022 fiscal period end). Shareholders have been substantially diluted in the past year (90% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (8.6% average weekly change). Revenue is less than US$5m (ج.م53m revenue, or US$1.7m). Market cap is less than US$100m (ج.م662.9m market cap, or US$21.5m).
Valuation Update With 7 Day Price Move • Nov 07Investor sentiment improves as stock rises 41%After last week's 41% share price gain to ج.م1.01, the stock trades at a trailing P/E ratio of 75.3x. Average trailing P/E is 8x in the Packaging industry in Africa. Total returns to shareholders of 207% over the past three years.
Buying Opportunity • Oct 08Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 24%. The fair value is estimated to be ج.م0.80, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 32% over the last year. Earnings per share has grown by 47%.
New Risk • Aug 17New major risk - Financial data availabilityThe company's latest financial reports are more than a year old. Last reported fiscal period ended June 2022. This is considered a major risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. In the worst case scenario, it may be facing other major going concern issues jeopardizing its viability as a listed company. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported June 2022 fiscal period end). Share price has been highly volatile over the past 3 months (16% average weekly change). Shareholders have been substantially diluted in the past year (90% increase in shares outstanding). Minor Risks Revenue is less than US$5m (ج.م53m revenue, or US$1.7m). Market cap is less than US$100m (ج.م472.3m market cap, or US$15.3m).
Buying Opportunity • Feb 24Now 25% undervalued after recent price dropOver the last 90 days, the stock is down 23%. The fair value is estimated to be ج.م0.37, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 22% per annum over the last 3 years. The company has become profitable over the last 3 years.
Is New 90 Day High Low • Mar 16New 90-day high: ج.م1.06The company is up 121% from a price of ج.م0.48 on 16 December 2020. Outperformed the Egyptian market which is up 4.0% over the last 90 days. Exceeded the Packaging industry, which is up 31% over the same period.
Reported Earnings • Mar 07Full year 2020 earnings released: EPS ج.م0.01 (vs ج.م0.017 in FY 2019)The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2020 results: Revenue: ج.م36.7m (up 23% from FY 2019). Net income: ج.م4.41m (down 21% from FY 2019). Profit margin: 12% (down from 19% in FY 2019). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 103% per year but the company’s share price has only increased by 70% per year, which means it is significantly lagging earnings growth.
Is New 90 Day High Low • Feb 01New 90-day high: ج.م0.81The company is up 134% from its price of ج.م0.35 on 03 November 2020. The Egyptian market is up 14% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Packaging industry, which is up 36% over the same period.
Is New 90 Day High Low • Jan 13New 90-day high: ج.م0.64The company is up 58% from its price of ج.م0.41 on 15 October 2020. The Egyptian market is up 5.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Packaging industry, which is up 25% over the same period.
Is New 90 Day High Low • Dec 17New 90-day high: ج.م0.53The company is up 14% from its price of ج.م0.46 on 17 September 2020. The Egyptian market is up 4.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Packaging industry, which is up 26% over the same period.
Is New 90 Day High Low • Nov 02New 90-day low: ج.م0.34The company is down 9.0% from its price of ج.م0.38 on 04 August 2020. The Egyptian market is up 4.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Packaging industry, which is up 4.0% over the same period.
お知らせ • Sep 17An unknown buyer acquired 11.4% stake in Medical Packaging Company (CASE:MEPA) from Wael Bebawy for EGP 15.6 million.An unknown buyer acquired 11.4% stake in Medical Packaging Company (CASE:MEPA) from Wael Bebawy for EGP 15.6 million on September 16, 2020. Wael Bebawy now holds 5.07% stake in Medical Packaging Company. An unknown buyer completed the acquisition of 11.4% stake in Medical Packaging Company (CASE:MEPA) from Wael Bebawy on September 16, 2020.